The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 329 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is N  [Clear All Filters]
2023
Cepaityte, D., Leivaditis K., Varouktsi G., Roumeliotis A., Roumeliotis S., & Liakopoulos V. (2023).  N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory properties.. Int Urol Nephrol. 55(6), 1481-1492.
Tsikopoulos, K., Meroni G., Kaloudis P., Pavlidou E., Gravalidis C., Tsikopoulos I., et al. (2023).  Is nanomaterial- and vancomycin-loaded polymer coating effective at preventing methicillin-resistant Staphylococcus aureus growth on titanium disks? An in vitro study.. Int Orthop.
Green, K., Panagopoulou P., D'Arco F., O'Hare P., Bowman R., Walters B., et al. (2023).  A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes.. Neuro Oncol. 25(4), 774-785.
Pavlidis, E. T., & Pavlidis T. E. (2023).  New trends in the surgical management of soft tissue sarcoma: The role of preoperative biopsy.. World J Clin Oncol. 14(2), 89-98.
Polyzos, S. A., & Kountouras J. (2023).  Nonalcoholic fatty liver disease and Helicobacter pylori infection. Is it time to address this potential relationship?. Curr Vasc Pharmacol.
Polyzos, S. A., Chrysavgis L., Vachliotis I. D., Chartampilas E., & Cholongitas E. (2023).  Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy.. Semin Cancer Biol. 93, 20-35.
Polyzos, S. A., Papaefthymiou A., Doulberis M., & Kountouras J. (2023).  Nonalcoholic fatty liver disease test: an external validation cohort.. Hormones (Athens).
2022
Iliadou, P., Bakirtzis C., Ioannidis P., Possin K., Zygouris S., Sintila S-A., et al. (2022).  Neuropsychological correlates of cerebellar volumes in multiple sclerosis: an MRI volumetric analysis study. Journal of Integrative Neuroscience. 21(1), 013.
Grammatikopoulou, M. G., Gkouskou K. K., Gkiouras K., Bogdanos D. P., Eliopoulos A. G., & Goulis D. G. (2022).  The Niche of n-of-1 Trials in Precision Medicine for Weight Loss and Obesity Treatment: Back to the Future.. Curr Nutr Rep. 11(2), 133-145.
Vachliotis, I. D., Anastasilakis A. D., Goulas A., Goulis D. G., & Polyzos S. A. (2022).  Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications.. Diabetes Obes Metab. 24(9), 1702-1720.
Muzurović, E., Polyzos S., Mikhailidis D., Borozan S., Novosel D., Cmiljanić O., et al. (2022).  Non-alcoholic fatty liver disease in children.. Curr Vasc Pharmacol.
Pafili, K., Paschou S. A., Armeni E., Polyzos S. A., Goulis D. G., & Lambrinoudaki I. (2022).  Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones.. J Endocrinol Invest.
Nikolaidou, B., Anyfanti P., Gavriilaki E., Lazaridis A., Triantafyllou A., Zarifis H., et al. (2022).  Non-dipping pattern in early-stage diabetes: association with glycemic profile and hemodynamic parameters.. J Hum Hypertens. 36(9), 805-810.
Doumas, A., Zegkos T., Parcharidou D., Gossios T., Ntelios D., Chatzileontiadou S., et al. (2022).  A novel quantitative method for assessing the therapeutic response to Tafamidis therapy in patients with cardiac TTR amyloidosis. A preliminary report.. Hell J Nucl Med. 25(2), 216-219.
Bakkum, M., Loobeek B., Richir M., & Papaioannidou P. (2022).  Novel teaching resources for the European Open Platform for Prescribing Education (EurOP2E) – a nominal group technique study. European Journal of Clinical Pharmacology .

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.